Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Assessment of hepatitis c virus-human immunodeficiency virus co-infection among human immunodeficiency virus patients on anti-retroviral therapy at public secondary care hospitals in a north-central senatorial district, Nigeria

  • At: Seville (Spain) (2022)
  • Type: Poster
  • Poster code: PPR-057
  • By: WILLIAMS, Felicia (University of Ilorin, Nigeria)
  • Co-author(s): Dr Felicia Williams, Lecturer, Department of Clinical Pharmacy & Pharmacy Practice (University of Ilorin, Ilorin, Nigeria)
    Dr David Adje, Clinical Pharmacy and Pharmacy Administration (Delta State University, Abraka, Nigeria)
    Pharm Jane-frances John-Benson, Clinical Pharmacy and Pharmacy Practice (University of Ilorin, Ilorin, Nigeria)
    Pharm Winifred Giwa, Clinical Pharmacy and Pharmacy Practice (University of Ilorin, Ilorin, Nigeria)
    Dr Louis Odeigah, Department of Family Medicine (University of Ilorin, Ilorin, Nigeria)
  • Abstract:

    Introduction: One of the infectious diseases that cause significant morbidity and mortality in human immunodeficiency virus (HIV) -infected individuals globally is the hepatitis C virus (HCV) infection. The co-infection is associated with higher rates of end-stage liver disease-related deaths when compared with HCV mono-infection. Hepatitis C..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses